Kolexia
Dailly Eric Pharmacien
Dailly Eric
Pharmacien
Hôpital Hôtel-Dieu Nantes
Nantes, France
79 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Intoxication COVID-19 Endocardite Alcoolisme Infection croisée Méningite Obésité morbide Infection de plaie opératoire

Collaborateurs

Voir plus
Deslandes Guillaume
Deslandes Guillaume
Hôpital Hôtel-Dieu Nantes, Nantes, France
Jolliet Pascale
Jolliet Pascale
Hôpital Hôtel-Dieu Nantes, Nantes, France
Bouquie Regis
Bouquie Regis
Chs Leon Jean Gregory, Thuir, France
Bellouard Ronan
Bellouard Ronan
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
The Journal of antimicrobial chemotherapy   21 octobre 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Open forum infectious diseases   20 octobre 2023
Pantoprazole promotes sustained intestinal carriage of multidrug-resistant Escherichia coli in amoxicillin-treated mice.
Journal of applied microbiology   14 octobre 2023
Development of an a priori tool to determine the frequency of dalbavancin administrations using a population pharmacokinetic approach
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Dalbavancin plasma concentrations in 133 patients: A PK-PD observational study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project.
The Journal of antimicrobial chemotherapy   02 juin 2023
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
The Journal of antimicrobial chemotherapy   04 avril 2023
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.
Antibiotics (Basel, Switzerland)   09 janvier 2023